Portal de Periódicos da CAPES

NAB 365, a beta 2‐receptor sympathomimetic agent: clinical experience in horses with lung disease

1978; Wiley; Volume: 1; Issue: 3 Linguagem: Inglês

10.1111/j.1365-2885.1978.tb00333.x

1365-2885

II. L. SASSE, R. Hajer,

Respiratory and Cough-Related Research

Journal of Veterinary Pharmacology and TherapeuticsVolume 1, Issue 3 p. 241-244 NAB 365, a beta 2-receptor sympathomimetic agent: clinical experience in horses with lung disease II. L. SASSE, II. L. SASSE Department of Large Animal Medicine, State University of Utrecht, Yalelaan 16, Utrecht, The Netherlands.Search for more papers by this authorR. HAJER, R. HAJER Department of Large Animal Medicine, State University of Utrecht, Yalelaan 16, Utrecht, The Netherlands.Search for more papers by this author II. L. SASSE, II. L. SASSE Department of Large Animal Medicine, State University of Utrecht, Yalelaan 16, Utrecht, The Netherlands.Search for more papers by this authorR. HAJER, R. HAJER Department of Large Animal Medicine, State University of Utrecht, Yalelaan 16, Utrecht, The Netherlands.Search for more papers by this author First published: September 1978 https://doi.org/10.1111/j.1365-2885.1978.tb00333.xCitations: 31AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Curti, P.C. (1974) Untersuchungen zur klinischen Pharmakologie eines neuen spezifisch-adrenergischen 2-Bronchodilatators. International Journal of Clinical Pharmacology, 9, 305–313. CASPubMedWeb of Science®Google Scholar Iravani, J. & Melville, G.N. (1974) Wirkung von Bromhexin-Metabolit VIII und ein neuen adrenergen Stoff auf die Mukoziliäre Funktion des Respirationstraktes. Arzneimittel Forschung 24, 849–855. CASPubMedWeb of Science®Google Scholar Kreuter, G. (1974) Orale Behandlung chronisch obstruktiver Atemwegerkrankungen. Untersuchungen zu Wirkungsunterschieden zwischen Tabletten und Zerbeisskapseln von Clenbuterol (NAB 365). Therapie der Gegenwart, 113, 1166–1191. CASPubMedWeb of Science®Google Scholar McPherson, E.A., Lawson, G.H., Murphy, J.R., Nicholson, J.M. & Fraser, J.A. (1978) Chronic obstructive pulmonary disease (C.O.P.D.): identification of affected horses. Equine Veterinary Journal, 10, 47–53. 10.1111/j.2042-3306.1978.tb02215.x CASPubMedWeb of Science®Google Scholar Muylle, E. & Oyaert, W. (1973) Lung function tests in obstructive pulmonary disease in horses. Equine Veterinary Journal, 5, 37–44. 10.1111/j.2042-3306.1973.tb03191.x CASPubMedGoogle Scholar Sasse, H.H.L. (1971) Some Pulmonary Function Tests in Horses. Unpublished Thesis, University of Utrecht. Google Scholar Sasse, H.H.L. (1973) Lungenfunktionprüfung beim Pferd. Tierärtzliche Praxis, I, 49–59. Google Scholar Sasse, H.H.L. & Hajer, R. (1977) Enkele veterinair-klinische ervaringen met het gebruik van een γ 2-receptoren stimulerend sympaticomymeticum (NAB 365R) bij paarden met longaandoeningen. Tydschrift voor Diergeneeskunde, 102, 1237–1238. (English summary). Google Scholar Uhl, O. (1974) Akkumulative Dosiswirkungsstudie zum Einfluss von NAB 365 und Fenoterol auf Lungenfunktionswerte, Blutdruck, Puls-frequenz und Allgemein-verträglichkeit. Arzncimittel Forschung, 24, 857–858. Google Scholar Citing Literature Volume1, Issue3September 1978Pages 241-244 ReferencesRelatedInformation